Working Papers
Decoupling Research from Development (Hou-Ning and Reeb)
To centralize or not: Control right allocation and auditor incentives (Gong, Lin, and Reeb)
Decoupling Research from Development (Hou-Ning and Reeb)
To centralize or not: Control right allocation and auditor incentives (Gong, Lin, and Reeb)
Research Interests and Expertise
Accounting statements; Ambiguity aversion, Analyst forecasts; Angel funds; Bank regulation; Bankruptcy; Bibliometrics; Bond markets; Bond pricing; Capital budgeting; CEO compensation; CEO Pay; Contracts; Corporate diversification; Corporate finance; Corporate governance; Debt financing, Decision-making; Disclosure quality; Dividend policy; Entrepreneurial finance; Exchange rate risk; Executive compensation; Family Firms; Federal Reserve; Financial Analysts; Financial distress; Financial Intermediation; Financial markets; Financial reporting; Financial statement reliability; Food and drug administration (FDA); Foreign direct investment; Hedge funds; Information Economics; Innovation; Insider Trading; Intellectual property; International finance; Investment banking; Law and finance; Mandatory disclosure; Mergers and acquisitions; Mortgage funds; Mutual funds; Patents; Pensions; Portfolio choice; Portfolio design; Private equity; Regulatory capture; Research and development (R&D); Retirement planning; Securities and Exchange Commission (SEC); Security prices; Singapore private equity, Sovereign wealth funds; Stock market development; Stock options; Syndicated loans; Treasury securities; Uncertainty; Venture capital; Voluntary disclosure; Wealth Management; Yield spreads;
Accounting statements; Ambiguity aversion, Analyst forecasts; Angel funds; Bank regulation; Bankruptcy; Bibliometrics; Bond markets; Bond pricing; Capital budgeting; CEO compensation; CEO Pay; Contracts; Corporate diversification; Corporate finance; Corporate governance; Debt financing, Decision-making; Disclosure quality; Dividend policy; Entrepreneurial finance; Exchange rate risk; Executive compensation; Family Firms; Federal Reserve; Financial Analysts; Financial distress; Financial Intermediation; Financial markets; Financial reporting; Financial statement reliability; Food and drug administration (FDA); Foreign direct investment; Hedge funds; Information Economics; Innovation; Insider Trading; Intellectual property; International finance; Investment banking; Law and finance; Mandatory disclosure; Mergers and acquisitions; Mortgage funds; Mutual funds; Patents; Pensions; Portfolio choice; Portfolio design; Private equity; Regulatory capture; Research and development (R&D); Retirement planning; Securities and Exchange Commission (SEC); Security prices; Singapore private equity, Sovereign wealth funds; Stock market development; Stock options; Syndicated loans; Treasury securities; Uncertainty; Venture capital; Voluntary disclosure; Wealth Management; Yield spreads;
